News Summary

• Venture capitalist Vinod Khosla said artificial intelligence (AI) is rapidly expanding drug discovery.
• He argued that the industry needs a more human-relevant approach to evaluating potential treatments.
• He pointed to Vivodyne, a biotechnology company developing technology to test drugs using living human tissues at scale.
• "We are still using 18th-century style animal testing," he wrote in a blog post on X.
• "Instead, @Vivodyne is evaluating drugs in livinghuman tissues at industrial scale"